Delivery of toll-like receptor 3 ligand poly(I:C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect in a mouse model
Authors:
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 133, 297-307
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB/Transregio 60)
- National Natural Science Foundation of China (81461130019, 81672022)
This publication has 35 references indexed in Scilit:
- Immunization with Biodegradable Nanoparticles Efficiently Induces Cellular Immunity and Protects against Influenza Virus InfectionThe Journal of Immunology, 2013
- New insight in the pathobiology of hepatitis B virus infectionGut, 2012
- Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteriaBiomaterials, 2009
- Early kinetics of innate and adaptive immune responses during hepatitis B virus infectionGut, 2009
- Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in miceHepatology, 2007
- An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infectionProceedings of the National Academy of Sciences, 2006
- Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In VivoJournal of Virology, 2005
- The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral toleranceJournal of Experimental Medicine, 2005
- Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticlesBiomaterials, 2005
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001